Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Vex: Vitamin D for Atopic Dermatitis
NCT03257215Phase 4Terminated
- Sponsor
- Murdoch Children's Research Institute
- Start
- Oct 2017
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vitamin d in atopic dermatitis (AD) (3 arms), sponsored by Murdoch Children's Research Institute. Primary endpoint: Change in SCORAD at 3 months. Started Oct 2017; status: terminated.
02
Drugs
vitamin d
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03257215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03257215.